Given the prior links made between Ezh2 overexpression and the more aggressive forms of prostate cancer (Varambally et al. 2002, 2008), we used genetically engineered mouse models of prostate cancer to investigate the role of the enzyme in carcinogenesis. The gene discussed is EZH2; the disease is prostate cancer.